A polymorphism in the CYP17 gene is associated with male breast cancer
1999
CYP17 Gene and Male Breast Cancer Risk
publication
Author Information
Author(s): Young I E, Kurian K M, Annink C, Kunkler I H, Anderson V A, Cohen B B, Hooper M L, Wyllie A H, Steel C M
Primary Institution: University of Edinburgh
Hypothesis
Is there an association between a polymorphism in the CYP17 gene and male breast cancer risk?
Conclusion
The study found that a polymorphism in the CYP17 gene is linked to a higher risk of male breast cancer.
Supporting Evidence
- The CYP17 gene is involved in estrogen synthesis.
- The study indicates a genetic risk factor for male breast cancer.
Takeaway
This study suggests that a specific change in a gene can make men more likely to get breast cancer.
Methodology
This is a case-control study conducted in South East Scotland.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website